Ronald D Ennis MD
Gynecologic Cancer, Urologic Cancer
Cancer Institute of New Jersey
Join to View Full Profile
1000 10th AveLower LevelNew York, NY 10019
Phone+1 212-523-7165
Fax+1 212-523-8189
Dr. Ennis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ronald Ennis is a Professor of Radiation Oncology at The Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Barnabas Health. He is the Vice Chair of Network Integration and Quality for radiation oncology. In this role he seeks of bring the radiation oncology departments of the RWJBH/CINJ system together as a unified entity. He has served on the Board of Directors of the American Society for Radiation Oncology (ASTRO) in the role of Government Relations Chair and serves on the Advisory Committee for the Medical Use of Isotopes at the U.S. Nuclear Regulatory Commission. He was elected Fellow of ASTRO in 2020. He received his medical degree from Yale School of Medicine and has been in practice 27 years. He specializes in gynecologic cancer and urologic cancer. He has more than 70 publications and over 500 citings.
Education & Training
Yale-New Haven Medical CenterResidency, Radiation Oncology, 1991 - 1994
Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1990 - 1991
Yale School of MedicineClass of 1990
Certifications & Licensure
NJ State Medical License 2013 - 2027
NY State Medical License 1994 - 2026
CT State Medical License 1992 - 2005
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Castle Connolly Best Doctors
Clinical Trials
- Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy Start of enrollment: 2007 Feb 01
- Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy Start of enrollment: 2013 Aug 01
- To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation Therapy.Philip Sutera, Kim Van der Eecken, Yang Song, Amol C Shetty, Elai Davicioni
European Urology Oncology. 2025-09-20 - Evaluation of the European Society of Medical Oncology-Magnitude of Clinical Benefit Scale Version 1.1 for the Treatment of Extracranial Oligometastatic Non-Small Cell...James B Yu, Benjamin W Corn, Summer S Qureshi, Vikram Jairam, Lucy M Yu
Practical Radiation Oncology. 2025-08-25 - Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer.Theodore Wang, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson
Translational Cancer Research. 2024-11-30
Journal Articles
- Prevalence of Surface Contamination with SARS-CoV-2 in a Radiation Oncology ClinicMutlay Sayan, Ronald D Ennis, Bruce G Haffty, JAMA Oncology
Authored Content
- Prevalence of Surface Contamination with SARS-CoV-2 in a Radiation Oncology ClinicAugust 2020
- Prevalence of Surface Contamination with SARS-CoV-2 in a Radiation Oncology ClinicAugust 2020
- Prevalence of Surface Contamination with SARS-CoV-2 in a Radiation Oncology ClinicAugust 2020
Press Mentions
Radiation Therapy as Effective as Surgery for Prostate CancerJune 6th, 2022
Rutgers Cancer Institute of New Jersey Doctors Named Among ‘Tops’ in Oncology CareJuly 23rd, 2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
